Christine Vaupel

Christine Vaupel, PhD, is the Global Lead for Precision Medicine Capabilities at Novartis Oncology. She is dedicated to enhancing patient outcomes through innovative healthcare strategies and impactful solutions. Dr. Vaupel has a strong background in Precision Medicine and Oncology Biomarkers, focusing on developing diagnostic capabilities that align with the evolving landscape of cancer treatment.1

In her role at Novartis, she emphasizes the importance of precision medicine in oncology, aiming to bridge gaps in cancer care and improve overall patient management. Her professional journey reflects a commitment to advancing healthcare through collaboration and innovation, particularly in the context of diagnostics and integrated solutions within oncology.12